Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Chiroptera | 3 | 2017 | 3530 | 0.52 | Why? |
| Nucleic Acids | 1 | 2018 | 435 | 0.50 | Why? |
| Camelus | 3 | 2017 | 1425 | 0.48 | Why? |
| Sequence Analysis, RNA | 2 | 2020 | 2290 | 0.45 | Why? |
| Zoonoses | 4 | 2020 | 3034 | 0.43 | Why? |
| Whole Genome Sequencing | 3 | 2021 | 3239 | 0.43 | Why? |
| Viruses | 3 | 2018 | 2238 | 0.40 | Why? |
| Genome, Viral | 14 | 2021 | 13157 | 0.36 | Why? |
| Phylogeny | 12 | 2021 | 13341 | 0.30 | Why? |
| Kenya | 3 | 2017 | 887 | 0.30 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 8 | 2019 | 8843 | 0.28 | Why? |
| United Arab Emirates | 5 | 2017 | 704 | 0.27 | Why? |
| Severe Acute Respiratory Syndrome | 9 | 2010 | 12361 | 0.27 | Why? |
| SARS Virus | 9 | 2010 | 13021 | 0.26 | Why? |
| Communicable Diseases | 1 | 2018 | 2148 | 0.25 | Why? |
| Virus Diseases | 2 | 2017 | 3779 | 0.25 | Why? |
| Sequence Analysis, DNA | 4 | 2020 | 2830 | 0.23 | Why? |
| Metagenomics | 2 | 2017 | 823 | 0.22 | Why? |
| Panthera | 1 | 2020 | 42 | 0.22 | Why? |
| Animals, Zoo | 1 | 2020 | 106 | 0.21 | Why? |
| Camping | 1 | 2021 | 76 | 0.21 | Why? |
| RNA, Viral | 9 | 2021 | 32276 | 0.20 | Why? |
| Respiratory Tract Infections | 2 | 2017 | 6817 | 0.19 | Why? |
| Genetic Variation | 4 | 2021 | 3919 | 0.19 | Why? |
| DNA Probes | 1 | 2018 | 178 | 0.17 | Why? |
| Coronavirus Infections | 17 | 2020 | 253789 | 0.16 | Why? |
| Community-Acquired Infections | 2 | 2020 | 2328 | 0.15 | Why? |
| Membrane Glycoproteins | 2 | 2005 | 2273 | 0.15 | Why? |
| Ships | 2 | 2021 | 1046 | 0.15 | Why? |
| Terminology as Topic | 1 | 2021 | 546 | 0.15 | Why? |
| Sequence Deletion | 1 | 2019 | 674 | 0.14 | Why? |
| Washington | 4 | 2020 | 1722 | 0.14 | Why? |
| Conserved Sequence | 1 | 2017 | 751 | 0.14 | Why? |
| Recombination, Genetic | 2 | 2017 | 1265 | 0.13 | Why? |
| Genomics | 2 | 2018 | 3118 | 0.13 | Why? |
| Amino Acid Sequence | 2 | 2017 | 6049 | 0.12 | Why? |
| Viral Envelope Proteins | 2 | 2005 | 3539 | 0.12 | Why? |
| Sentinel Surveillance | 1 | 2020 | 1093 | 0.12 | Why? |
| Open Reading Frames | 3 | 2019 | 1898 | 0.12 | Why? |
| Phylogeography | 1 | 2017 | 824 | 0.12 | Why? |
| Animals | 13 | 2020 | 78931 | 0.12 | Why? |
| Nucleocapsid Proteins | 1 | 2004 | 3120 | 0.12 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2020 | 1439 | 0.12 | Why? |
| Coronavirus | 2 | 2012 | 18339 | 0.11 | Why? |
| Skilled Nursing Facilities | 1 | 2020 | 1098 | 0.11 | Why? |
| Epidemiological Monitoring | 3 | 2021 | 3493 | 0.11 | Why? |
| Coronaviridae | 1 | 2017 | 923 | 0.11 | Why? |
| Sequence Alignment | 2 | 2020 | 2109 | 0.11 | Why? |
| Coronavirus NL63, Human | 1 | 2017 | 669 | 0.11 | Why? |
| Crowding | 1 | 2017 | 731 | 0.11 | Why? |
| Virus Replication | 3 | 2021 | 14331 | 0.10 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.10 | Why? |
| Base Sequence | 3 | 2019 | 3581 | 0.10 | Why? |
| Endothelium, Vascular | 1 | 2021 | 1751 | 0.10 | Why? |
| Polymerase Chain Reaction | 3 | 2017 | 6740 | 0.10 | Why? |
| Evolution, Molecular | 2 | 2017 | 3691 | 0.09 | Why? |
| Respiratory System | 1 | 2021 | 3213 | 0.09 | Why? |
| Georgia | 2 | 2022 | 955 | 0.09 | Why? |
| Disease Outbreaks | 7 | 2021 | 27595 | 0.09 | Why? |
| Disease Transmission, Infectious | 3 | 2021 | 9044 | 0.09 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.08 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.08 | Why? |
| Laboratories | 2 | 2021 | 2858 | 0.08 | Why? |
| Molecular Sequence Data | 1 | 2012 | 3198 | 0.08 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3633 | 0.08 | Why? |
| Cross Infection | 3 | 2019 | 8675 | 0.08 | Why? |
| Humans | 38 | 2022 | 930598 | 0.07 | Why? |
| Viverridae | 1 | 2005 | 225 | 0.07 | Why? |
| Travel | 5 | 2021 | 7220 | 0.07 | Why? |
| California | 2 | 2021 | 2047 | 0.07 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.06 | Why? |
| Genotype | 3 | 2021 | 4697 | 0.06 | Why? |
| Saudi Arabia | 3 | 2019 | 4423 | 0.06 | Why? |
| Communicable Disease Control | 3 | 2016 | 29620 | 0.06 | Why? |
| Viral Tropism | 2 | 2021 | 1329 | 0.06 | Why? |
| Diamond | 1 | 2021 | 55 | 0.06 | Why? |
| Point Mutation | 1 | 2004 | 481 | 0.06 | Why? |
| Viral Proteins | 2 | 2017 | 7370 | 0.05 | Why? |
| Amino Acid Substitution | 2 | 2005 | 1706 | 0.05 | Why? |
| Louisiana | 1 | 2021 | 353 | 0.05 | Why? |
| Feces | 3 | 2009 | 4235 | 0.05 | Why? |
| In Situ Hybridization | 1 | 2021 | 390 | 0.05 | Why? |
| Mutation, Missense | 1 | 2004 | 863 | 0.05 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.05 | Why? |
| Sequence Analysis | 1 | 2020 | 496 | 0.05 | Why? |
| Male | 18 | 2021 | 367725 | 0.04 | Why? |
| Likelihood Functions | 1 | 2020 | 719 | 0.04 | Why? |
| Contact Tracing | 4 | 2022 | 8448 | 0.04 | Why? |
| Hospitals | 2 | 2016 | 11793 | 0.04 | Why? |
| Adult | 14 | 2021 | 244371 | 0.04 | Why? |
| Lung | 4 | 2021 | 31049 | 0.04 | Why? |
| Polymorphism, Genetic | 1 | 2004 | 1074 | 0.04 | Why? |
| 5' Untranslated Regions | 1 | 2019 | 375 | 0.04 | Why? |
| Haplotypes | 1 | 2020 | 853 | 0.04 | Why? |
| Young Adult | 7 | 2021 | 93724 | 0.04 | Why? |
| New York City | 2 | 2020 | 7432 | 0.04 | Why? |
| United States | 6 | 2021 | 46150 | 0.04 | Why? |
| Communicable Diseases, Emerging | 2 | 2016 | 2523 | 0.04 | Why? |
| Cell Line | 3 | 2020 | 12040 | 0.04 | Why? |
| Emergency Responders | 1 | 2021 | 479 | 0.04 | Why? |
| Blood Chemical Analysis | 1 | 2020 | 541 | 0.04 | Why? |
| Oropharynx | 2 | 2020 | 1581 | 0.04 | Why? |
| One Health | 1 | 2020 | 390 | 0.04 | Why? |
| Female | 15 | 2021 | 380317 | 0.04 | Why? |
| Genes, Viral | 2 | 2015 | 1428 | 0.04 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.03 | Why? |
| Jordan | 1 | 2017 | 701 | 0.03 | Why? |
| Patient Acuity | 1 | 2021 | 1755 | 0.03 | Why? |
| Adolescent | 6 | 2021 | 86841 | 0.03 | Why? |
| Aged | 9 | 2021 | 215776 | 0.03 | Why? |
| Travel-Related Illness | 1 | 2020 | 1357 | 0.03 | Why? |
| Infant | 3 | 2021 | 30274 | 0.03 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.03 | Why? |
| Prisons | 1 | 2021 | 980 | 0.03 | Why? |
| Child, Preschool | 3 | 2021 | 36283 | 0.03 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 11367 | 0.03 | Why? |
| Bayes Theorem | 1 | 2020 | 3237 | 0.03 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.02 | Why? |
| Autopsy | 1 | 2021 | 3495 | 0.02 | Why? |
| Carrier State | 1 | 2021 | 2100 | 0.02 | Why? |
| Cluster Analysis | 1 | 2017 | 3001 | 0.02 | Why? |
| Viral Vaccines | 1 | 2010 | 7560 | 0.02 | Why? |
| Dipeptidyl Peptidase 4 | 1 | 2016 | 1061 | 0.02 | Why? |
| Child | 4 | 2021 | 70012 | 0.02 | Why? |
| Greece | 1 | 2015 | 2091 | 0.02 | Why? |
| Immunohistochemistry | 1 | 2016 | 2275 | 0.02 | Why? |
| World Health Organization | 1 | 2021 | 4213 | 0.02 | Why? |
| Radiography | 1 | 2016 | 1576 | 0.02 | Why? |
| Vero Cells | 2 | 2020 | 14117 | 0.02 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.02 | Why? |
| Incidence | 2 | 2021 | 25622 | 0.02 | Why? |
| Fatal Outcome | 1 | 2016 | 3438 | 0.02 | Why? |
| Cough | 1 | 2020 | 4891 | 0.02 | Why? |
| Schools | 1 | 2022 | 4187 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Health Personnel | 3 | 2021 | 29646 | 0.02 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 13720 | 0.02 | Why? |
| Students | 1 | 2022 | 5255 | 0.02 | Why? |
| Communication | 1 | 2021 | 5206 | 0.02 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2017 | 37182 | 0.02 | Why? |
| Fever | 1 | 2020 | 7795 | 0.02 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.02 | Why? |
| Equipment and Supplies, Hospital | 1 | 2004 | 272 | 0.01 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Species Specificity | 1 | 2005 | 1356 | 0.01 | Why? |
| Microscopy, Electron | 1 | 2003 | 830 | 0.01 | Why? |
| China | 3 | 2020 | 50654 | 0.01 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.01 | Why? |
| Infection Control | 2 | 2020 | 23131 | 0.01 | Why? |
| Environmental Microbiology | 1 | 2004 | 575 | 0.01 | Why? |
| DNA Primers | 1 | 2004 | 1170 | 0.01 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.01 | Why? |
| Antiviral Agents | 1 | 2010 | 41703 | 0.01 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.01 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.01 | Why? |
| Sputum | 1 | 2004 | 1720 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.01 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.01 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2003 | 2309 | 0.01 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.01 | Why? |
| DNA, Viral | 1 | 2004 | 2521 | 0.01 | Why? |
| Family Characteristics | 1 | 2004 | 2551 | 0.01 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2005 | 3607 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2004 | 11304 | 0.01 | Why? |
| Specimen Handling | 1 | 2004 | 6190 | 0.00 | Why? |
| Sensitivity and Specificity | 1 | 2004 | 22971 | 0.00 | Why? |
| Time Factors | 1 | 2004 | 31397 | 0.00 | Why? |
Tong's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(174)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(601)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_